Medical Developments International Limited
MDDVF
$0.37
$0.0721.99%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 7.08M | 7.06M | 6.11M | 5.98M | 6.51M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 7.08M | 7.06M | 6.11M | 5.98M | 6.51M |
| Cost of Revenue | 1.88M | 1.87M | 1.40M | 1.37M | 1.72M |
| Gross Profit | 5.20M | 5.18M | 4.71M | 4.61M | 4.80M |
| SG&A Expenses | 4.53M | 4.51M | 4.50M | 4.41M | 4.17M |
| Depreciation & Amortization | 448.30K | 446.90K | 514.40K | 503.70K | 520.30K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.85M | 6.83M | 6.42M | 6.28M | 6.40M |
| Operating Income | 224.50K | 223.80K | -307.80K | -301.40K | 108.20K |
| Income Before Tax | -75.20K | -74.90K | -47.70K | -46.70K | 103.30K |
| Income Tax Expenses | -1.00K | -1.00K | 19.50K | 19.10K | 4.20K |
| Earnings from Continuing Operations | -74.20K | -73.90K | -67.30K | -65.90K | 99.00K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -74.20K | -73.90K | -67.30K | -65.90K | 99.00K |
| EBIT | 224.50K | 223.80K | -307.80K | -301.40K | 108.20K |
| EBITDA | 672.80K | 670.60K | -62.30K | 25.80K | 628.50K |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 112.66M | 112.66M | 112.61M | 112.61M | 107.37M |
| Average Diluted Shares Outstanding | 112.66M | 112.66M | 112.61M | 112.61M | 112.58M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |